Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis

BACKGROUND: Immune checkpoint inhibitors and targeted therapies are approved for adjuvant treatment of patients with resected melanoma; however, they have not been compared in randomized controlled trials (RCTs). We compared the efficacy and safety of adjuvant nivolumab with other approved treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Toor, Kabirraaj, Middleton, Mark R., Chan, Keith, Amadi, Adenike, Moshyk, Andriy, Kotapati, Srividya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784366/
https://www.ncbi.nlm.nih.gov/pubmed/33402121
http://dx.doi.org/10.1186/s12885-020-07538-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784366/
https://www.ncbi.nlm.nih.gov/pubmed/33402121
http://dx.doi.org/10.1186/s12885-020-07538-1

Ejemplares similares